Ironwood Pharmaceuticals, Inc.

The momentum for this stock is not very good. Ironwood Pharmaceuticals, Inc. has good value characteristics. Ironwood Pharmaceuticals, Inc. is not very popular among insiders. Ironwood Pharmaceuticals, Inc. is a mediocre stock to choose.
Log in to see more information.
Ironwood Pharmaceuticals, Inc. is a commercial biotechnology company, which engages in the discovery...
IRWD Fundamental Data by TradingView

News

FY2024 EPS Estimates for Ironwood Pharmaceuticals, Inc. Cut by Zacks Research (NASDAQ:IRWD)
FY2024 EPS Estimates for Ironwood Pharmaceuticals, Inc. Cut by Zacks Research (NASDAQ:IRWD)

Zolmax Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Investment analysts at Zacks Research lowered their FY2024 EPS estimates for Ironwood Pharmaceuticals in a research note issued on...\n more…

Equities Analysts Offer Predictions for Ironwood Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:IRWD)
Equities Analysts Offer Predictions for Ironwood Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:IRWD)

Ticker Report Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Leerink Partnrs issued their FY2024 earnings per share (EPS) estimates for Ironwood Pharmaceuticals in a research report issued on Monday...\n more…

Research Analysts Set Expectations for Ironwood Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:IRWD)
Research Analysts Set Expectations for Ironwood Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:IRWD)

Zolmax Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Stock analysts at Leerink Partnrs issued their FY2024 earnings per share estimates for shares of Ironwood Pharmaceuticals in a research...\n more…

LSV Asset Management Sells 79,500 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
LSV Asset Management Sells 79,500 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Zolmax LSV Asset Management lowered its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 1.3% during the 2nd quarter, according to the company in its most recent disclosure with the...\n more…

Gallacher Capital Management LLC Buys 12,584 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
Gallacher Capital Management LLC Buys 12,584 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Ticker Report Gallacher Capital Management LLC lifted its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 72.4% in the 2nd quarter, according to the company in its most recent filing with...\n more…

Ironwood Pharmaceuticals (NASDAQ:IRWD) Upgraded by Leerink Partnrs to "Hold"
Ironwood Pharmaceuticals (NASDAQ:IRWD) Upgraded by Leerink Partnrs to "Hold"

Ticker Report Leerink Partnrs upgraded shares of Ironwood Pharmaceuticals (NASDAQ:IRWD - Free Report) to a hold rating in a research report sent to investors on Monday, Zacks.com reports. Leerink Partnrs also...\n more…